|
2017 |
Ting, KR;Henry, M;Meiller, J;Larkin, A;Clynes, M;Meleady, P;Bazou, D;Dowling, P;O'Gorman, P (2017) 'Novel panel of protein biomarkers to predict response to bortezomib-containing induction regimens in multiple myeloma patients'. BBA Clinical, 8 :28-34. |
|
2017 |
Kelly, PS;Clarke, C;Costello, A;Monger, C;Meiller, J;Dhiman, H;Borth, N;Betenbaugh, MJ;Clynes, M;Barron, N (2017) 'Ultra-deep next generation mitochondrial genome sequencing reveals widespread heteroplasmy in Chinese hamster ovary cells'. Metabolic Engineering, 41 :11-22. |
|
2016 |
Ting, KR;Brady, JJ;Hameed, A;Le, G;Meiller, J;Verburgh, E;Bayers, C;Benjamin, D;Anderson, KC;Richardson, PG;Dowling, P;Clynes, M;Fitzgibbon, MC;O'Gorman, P (2016) 'Clinical utility of C-terminal telopeptide of type 1 collagen in multiple myeloma'. British Journal of Haematology, 173 :82-88. |
|
2015 |
Dowling, P;Hughes, DJ;Larkin, AM;Meiller, J;Henry, M;Meleady, P;Lynch, V;Pardini, B;Naccarati, A;Levy, M;Vodicka, P;Neary, P;Clynes, M (2015) 'Elevated levels of 14-3-3 proteins, serotonin, gamma enolase and pyruvate kinase identified in clinical samples from patients diagnosed with colorectal cancer'. Clinica Chimica Acta, 441 :133-141. |
|
2014 |
Dowling, P;Hayes, C;Ting, KR;Hameed, A;Meiller, J;Mitsiades, C;Anderson, KC;Clynes, M;Clarke, C;Richardson, P;O'Gorman, P (2014) 'Identification of proteins found to be significantly altered when comparing the serum proteome from Multiple Myeloma patients with varying degrees of bone disease'. BMC Genomics, 15 . |
|
2013 |
O'Connor, R;Ooi, MG;Meiller, J;Jakubikova, J;Klippel, S;Delmore, J;Richardson, P;Anderson, K;Clynes, M;Mitsiades, CS;O'Gorman, P (2013) 'The interaction of bortezomib with multidrug transporters: implications for therapeutic applications in advanced multiple myeloma and other neoplasias'. Cancer Chemotherapy and Pharmacology, 71 :1357-1368. |
|
2012 |
Roche, S;Sewell, L;Meiller, J;Pedersen, K;Rajpal, R;O'Gorman, P;Clynes, M;O'Connor, R (2012) 'Development, validation and application of a sensitive LC-MS/MS method for the quantification of thalidomide in human serum, cells and cell culture medium'. Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, 902 :16-26. |
|
2011 |
Rajpal, R;Dowling, P;Meiller, J;Clarke, C;Murphy, WG;O'Connor, R;Kell, M;Mitsiades, C;Richardson, P;Anderson, KC;Clynes, M;O'Gorman, P (2011) 'A novel panel of protein biomarkers for predicting response to thalidomide-based therapy in newly diagnosed multiple myeloma patients'. Proteomics, 11 :1391-1402. |
